Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 96

1.

Reply to Chen Cheng, Sunxiang Ma, and Yang Liu's Letter to the Editor re: Dan Wood, Andrew Baird, Luca Carmignani, et al. Lifelong Congenital Urology: The Challenges for Patients and Surgeons. Eur Urol 2019;75:1001-7.

Wood D, Baird A, Carmignani L, De Win G, Hoebeke P, Holmdahl G, Manzoni G, Nijman RJM, Taylor C, Tekgul S.

Eur Urol. 2019 Oct;76(4):e94-e95. doi: 10.1016/j.eururo.2019.07.011. Epub 2019 Jul 18. No abstract available.

PMID:
31327638
2.

Safety and feasibility of thullium laser transurethral resection of prostate for the treatment of benign prostatic enlargement in overweight patients.

Carmignani L, Clementi MC, Signorini C, Motta G, Nazzani S, Palmisano F, De Lorenzis E, Catellani M, Mistretta AF, Conti A, Tringali V, Costa MB, Vizziello D.

Asian J Urol. 2019 Jul;6(3):270-274. doi: 10.1016/j.ajur.2018.05.004. Epub 2018 May 17.

3.

Surgically Treated Retroperitoneal Sarcoma: A Population-based Competing Risks Analysis.

Nazzani S, Preisser F, Bandini M, Marchioni M, Tian Z, Soulières D, Montanari E, Ratti D, Acquati P, Briganti A, Shariat SF, Abdollah F, Carmignani L, Karakiewicz PI.

Eur Urol Oncol. 2018 Sep;1(4):346-351. doi: 10.1016/j.euo.2018.05.008. Epub 2018 May 31.

PMID:
31100257
4.

Survival Effect of Nephroureterectomy in Metastatic Upper Urinary Tract Urothelial Carcinoma.

Nazzani S, Preisser F, Mazzone E, Marchioni M, Bandini M, Tian Z, Mistretta FA, Shariat SF, Soulières D, Saad F, Montanari E, Luzzago S, Briganti A, Carmignani L, Karakiewicz PI.

Clin Genitourin Cancer. 2019 Jun;17(3):e602-e611. doi: 10.1016/j.clgc.2019.03.003. Epub 2019 Mar 29.

PMID:
31005472
5.

Lifelong Congenital Urology: The Challenges for Patients and Surgeons.

Wood D, Baird A, Carmignani L, De Win G, Hoebeke P, Holmdahl G, Manzoni G, Nijman RJM, Taylor C, Tekgul S.

Eur Urol. 2019 Jun;75(6):1001-1007. doi: 10.1016/j.eururo.2019.03.019. Epub 2019 Mar 29. Review.

PMID:
30935758
6.

Postoperative paralytic ileus after major oncological procedures in the enhanced recovery after surgery era: A population based analysis.

Nazzani S, Bandini M, Preisser F, Mazzone E, Marchioni M, Tian Z, Stubinski R, Clementi MC, Saad F, Shariat SF, Montanari E, Briganti A, Carmignani L, Karakiewicz PI.

Surg Oncol. 2019 Mar;28:201-207. doi: 10.1016/j.suronc.2019.01.011. Epub 2019 Jan 29.

PMID:
30851901
7.

Comparison of perioperative outcomes between open and minimally invasive nephroureterectomy: A population-based analysis.

Nazzani S, Bazinet A, Preisser F, Mazzone E, Tian Z, Mistretta FA, Shariat SF, Saad F, Zorn KC, Montanari E, Briganti A, Carmignani L, Karakiewicz PI.

Int J Urol. 2019 Apr;26(4):487-492. doi: 10.1111/iju.13916. Epub 2019 Feb 12.

PMID:
30756440
8.

Rates of lymph node invasion and their impact on cancer specific mortality in upper urinary tract urothelial carcinoma.

Nazzani S, Mazzone E, Preisser F, Tian Z, Mistretta FA, Shariat SF, Montanari E, Acquati P, Briganti A, Saad F, Carmignani L, Karakiewicz PI.

Eur J Surg Oncol. 2019 Jul;45(7):1238-1245. doi: 10.1016/j.ejso.2018.12.004. Epub 2018 Dec 11.

PMID:
30563773
9.

Survival Effect of Chemotherapy in Metastatic Upper Urinary Tract Urothelial Carcinoma.

Nazzani S, Preisser F, Mazzone E, Marchioni M, Bandini M, Tian Z, Mistretta FA, Shariat SF, Soulières D, Montanari E, Acquati P, Briganti A, Carmignani L, Karakiewicz PI.

Clin Genitourin Cancer. 2019 Feb;17(1):e97-e103. doi: 10.1016/j.clgc.2018.09.017. Epub 2018 Sep 27.

PMID:
30337106
10.

Survival effect of perioperative systemic chemotherapy on overall mortality in locally advanced and/or positive regional lymph node non-metastatic urothelial carcinoma of the upper urinary tract.

Nazzani S, Preisser F, Mazzone E, Tian Z, Mistretta FA, Shariat SF, Soulières D, Saad F, Montanari E, Luzzago S, Briganti A, Carmignani L, Karakiewicz PI.

World J Urol. 2019 Jul;37(7):1329-1337. doi: 10.1007/s00345-018-2516-z. Epub 2018 Oct 8.

PMID:
30298285
11.

Nephroureterectomy with or without Bladder Cuff Excision for Localized Urothelial Carcinoma of the Renal Pelvis.

Nazzani S, Preisser F, Mazzone E, Tian Z, Mistretta FA, Soulières D, Montanari E, Acquati P, Briganti A, Shariat SF, Abdollah F, Carmignani L, Karakiewicz PI.

Eur Urol Focus. 2018 Sep 25. pii: S2405-4569(18)30279-7. doi: 10.1016/j.euf.2018.09.007. [Epub ahead of print]

PMID:
30266210
12.

Comparison of Perioperative Outcomes Between Open and Robotic Radical Cystectomy: A Population-Based Analysis.

Nazzani S, Mazzone E, Preisser F, Bandini M, Tian Z, Marchioni M, Ratti D, Motta G, Zorn KC, Briganti A, Shariat SF, Montanari E, Carmignani L, Karakiewicz PI.

J Endourol. 2018 Aug;32(8):701-709. doi: 10.1089/end.2018.0313. Epub 2018 Jul 2.

13.

In-hospital length of stay after major surgical oncological procedures.

Nazzani S, Preisser F, Mazzone E, Tian Z, Mistretta FA, Shariat SF, Saad F, Graefen M, Tilki D, Montanari E, Luzzago S, Briganti A, Carmignani L, Karakiewicz PI.

Eur J Surg Oncol. 2018 Jul;44(7):969-974. doi: 10.1016/j.ejso.2018.05.001. Epub 2018 May 9.

PMID:
29784507
14.

The Effect of Institution Teaching Status on Perioperative Outcomes After Robotic Partial or Radical Nephrectomy.

Marchioni M, Nazzani S, Preisser F, Bandini M, Tian Z, Kapoor A, Cindolo L, Primiceri G, Carmignani L, Briganti A, Montorsi F, Shariat SF, Schips L, Karakiewicz PI.

J Endourol. 2018 Jul;32(7):621-629. doi: 10.1089/end.2018.0025. Epub 2018 Jun 19.

PMID:
29739253
15.

A contemporary analysis of radiotherapy effect in surgically treated retroperitoneal sarcoma.

Nazzani S, Bandini M, Marchioni M, Preisser F, Tian Z, Soulières D, Montanari E, Motta G, Acquati P, Briganti A, Shariat SF, Abdollah F, Carmignani L, Karakiewicz PI.

Radiother Oncol. 2018 May;127(2):318-325. doi: 10.1016/j.radonc.2018.03.027. Epub 2018 Apr 6.

PMID:
29631934
16.

Risk factors for benign prostatic enlargement: The role of lifestyle habits at younger age. The #Controllati2017 initiative study group.

Mirone V, Carrieri G, Morgia G, Carmignani L, Vespasiani G, Parazzini F, Artibani W.

Arch Ital Urol Androl. 2017 Dec 31;89(4):253-258. doi: 10.4081/aiua.2017.4.253.

17.

Thulium Laser Treatment of Upper Urinary Tract Carcinoma: A Multi-Institutional Analysis of Surgical and Oncological Outcomes.

Musi G, Mistretta FA, Marenghi C, Russo A, Catellani M, Nazzani S, Conti A, Luzzago S, Ferro M, Matei DV, Carmignani L, de Cobelli O.

J Endourol. 2018 Mar;32(3):257-263. doi: 10.1089/end.2017.0915. Epub 2018 Feb 21.

PMID:
29357686
18.

Thulium-yttrium-aluminium-garnet (Tm:YAG) laser treatment of penile cancer: oncological results, functional outcomes, and quality of life.

Musi G, Russo A, Conti A, Mistretta FA, Di Trapani E, Luzzago S, Bianchi R, Renne G, Ramoni S, Ferro M, Matei DV, Cusini M, Carmignani L, de Cobelli O.

World J Urol. 2018 Feb;36(2):265-270. doi: 10.1007/s00345-017-2144-z. Epub 2017 Dec 2.

PMID:
29197968
19.

Re: Freire et al.: Deep Infiltrating Endometriosis-Urinary Tract Involvement and Predictive Factors for Major Surgery (Urology 2017;108:65-70).

Carmignani L, Signorini C.

Urology. 2018 Feb;112:226. doi: 10.1016/j.urology.2017.10.042. Epub 2017 Nov 16. No abstract available.

PMID:
29155189
20.

Adrenal Ganglioneuroblastoma in Adults: A Case Report and Review of the Literature.

Benedini S, Grassi G, Aresta C, Tufano A, Carmignani LF, Rubino B, Luzi L, Corbetta S.

Case Rep Endocrinol. 2017;2017:5796236. doi: 10.1155/2017/5796236. Epub 2017 Jun 21.

Supplemental Content

Loading ...
Support Center